Canaccord Genuity Group reaffirmed their buy rating on shares of ASP Isotopes (NASDAQ:ASPI – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock.
ASPI has been the topic of several other research reports. HC Wainwright decreased their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock.
Get Our Latest Stock Report on ASP Isotopes
ASP Isotopes Price Performance
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last announced its earnings results on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The firm had revenue of $1.02 million during the quarter. On average, equities analysts anticipate that ASP Isotopes will post -0.24 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP lifted its position in ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares during the period. Bank of New York Mellon Corp acquired a new position in ASP Isotopes during the 2nd quarter valued at about $381,000. HTLF Bank boosted its stake in shares of ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after purchasing an additional 70,000 shares during the last quarter. Finally, Virtu Financial LLC grew its position in shares of ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares during the period. 16.80% of the stock is currently owned by institutional investors.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Featured Stories
- Five stocks we like better than ASP Isotopes
- Insider Buying Explained: What Investors Need to Know
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- What to Know About Investing in Penny Stocks
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.